Neogen Chemicals Limited allotted 10,00,000 equity shares to promoter group member Cadamba Solutions Private Limited via a Rs. 161 Crore preferential issue. The shares were issued at Rs. 1,610 each, representing 3.65% of the post-allotment paid-up capital. This capital infusion strengthens the company's financial position for future growth.
Neogen Chemicals Limited has allotted 10,00,000 equity shares on a preferential basis to promoter group member Cadamba Solutions Private Limited. The allotment was priced at ₹1,610 per share, representing a total fundraise of ₹161.0 Crore. This capital infusion strengthens the company's financial position and increases its paid-up share capital.
Neogen Chemicals Limited allotted 10,00,000 equity shares to Cadamba Solutions Private Limited on a preferential basis, raising ₹161 Crore. The issue price was ₹1,610 per share, including a ₹1,600 premium. This allotment increases the company's paid-up equity capital to ₹27.38 Crore and the shares are subject to an 18-month lock-in period.
Dr. Harin Haridas Kanani, a promoter of Neogen Chemicals Limited, pledged 20,19,167 equity shares (7.65% stake) on April 13, 2026. The pledge was created in favour of Axis Trustee Services Limited to facilitate fund raising for Cadamba Solutions Private Limited, a promoter group member.
Axis Trustee Services Limited, acting as a Debenture Trustee, has received a pledge of 20,19,167 equity shares (7.65% stake) in Neogen Chemicals Limited. The transaction was executed on April 13, 2026, in its capacity as a pledgee. The trustee clarifies it holds no beneficial interest in the shares.
Neogen Chemicals Ltd submitted its half-yearly statement for NCDs totaling ₹200 Crore. The debentures, issued on August 12, 2025, carry a 10.50% monthly coupon and mature in February 2028. Both the issuer and holders have call/put options exercisable starting August 12, 2027.
Neogen Chemicals Ltd has fixed April 15, 2026, as the record date for the payment of interest on its listed Non-Convertible Debentures (ISIN: INE136S07013). The interest payment is scheduled to be made on April 30, 2026, in compliance with SEBI listing regulations.
